| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |